Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Garrett M Brodeur

Showing results (51-60 of 88) with videos related to

Pageof 9
Sort By:
Frontiers in Pediatrics|May 23, 2019
Gain-of-Function STAT1 Mutation With Familial Lymphadenopathy and Hodgkin LymphomaSarah E Henrickson, Joseph G Dolan, Lisa R Forbes, et al.
Pediatric Blood & Cancer|January 10, 2017
Management of adrenal masses in patients with Beckwith-Wiedemann syndromeSuzanne P MacFarland, Sogol Mostoufi-Moab, Kristin Zelley, et al.
Pediatric Blood & Cancer|October 13, 2011
Clinical significance of NTRK family gene expression in neuroblastomasJennifer E Light, Hiroshi Koyama, Jane E Minturn, et al.
Cancer Research|August 26, 2020
Structural Optimization and Enhanced Prodrug-Mediated Delivery Overcomes Camptothecin Resistance in High-Risk Solid TumorsFerro Nguyen, Peng Guan, David T Guerrero, et al.
Oncogene|January 8, 2005
Microarray analysis reveals differential gene expression patterns and regulation of single target genes contributing to the opposing phenotype of TrkA- and TrkB-expressing neuroblastomasJohannes H Schulte, Alexander Schramm, Ludger Klein-Hitpass, et al.
Biomaterials|March 16, 2015
Nanoparticle-mediated delivery of a rapidly activatable prodrug of SN-38 for neuroblastoma therapyIvan S Alferiev, Radhika Iyer, Jamie L Croucher, et al.
Oncogene|April 15, 2005
Definition and characterization of a region of 1p36.3 consistently deleted in neuroblastomaPeter S White, Patricia M Thompson, Takahiro Gotoh, et al.
Cancer Chemotherapy and Pharmacology|May 25, 2012
AZ64 inhibits TrkB and enhances the efficacy of chemotherapy and local radiation in neuroblastoma xenograftsRadhika Iyer, Carly R Varela, Jane E Minturn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 27, 2024
Adult-Onset Cancer Predisposition Syndromes in Children and Adolescents-To Test or not to Test?Christian P Kratz, Philip J Lupo, Kristin Zelley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2005
Outcomes of children with intermediate-risk neuroblastoma after treatment stratified by MYCN status and tumor cell ploidyRochelle Bagatell, Pavlina Rumcheva, Wendy B London, et al.
Pageof 9

Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
Frontiers in Pediatrics|May 23, 2019
Gain-of-Function STAT1 Mutation With Familial Lymphadenopathy and Hodgkin LymphomaSarah E Henrickson, Joseph G Dolan, Lisa R Forbes, et al.
Pediatric Blood & Cancer|January 10, 2017
Management of adrenal masses in patients with Beckwith-Wiedemann syndromeSuzanne P MacFarland, Sogol Mostoufi-Moab, Kristin Zelley, et al.
Pediatric Blood & Cancer|October 13, 2011
Clinical significance of NTRK family gene expression in neuroblastomasJennifer E Light, Hiroshi Koyama, Jane E Minturn, et al.
Cancer Research|August 26, 2020
Structural Optimization and Enhanced Prodrug-Mediated Delivery Overcomes Camptothecin Resistance in High-Risk Solid TumorsFerro Nguyen, Peng Guan, David T Guerrero, et al.
Oncogene|January 8, 2005
Microarray analysis reveals differential gene expression patterns and regulation of single target genes contributing to the opposing phenotype of TrkA- and TrkB-expressing neuroblastomasJohannes H Schulte, Alexander Schramm, Ludger Klein-Hitpass, et al.
Biomaterials|March 16, 2015
Nanoparticle-mediated delivery of a rapidly activatable prodrug of SN-38 for neuroblastoma therapyIvan S Alferiev, Radhika Iyer, Jamie L Croucher, et al.
Oncogene|April 15, 2005
Definition and characterization of a region of 1p36.3 consistently deleted in neuroblastomaPeter S White, Patricia M Thompson, Takahiro Gotoh, et al.
Cancer Chemotherapy and Pharmacology|May 25, 2012
AZ64 inhibits TrkB and enhances the efficacy of chemotherapy and local radiation in neuroblastoma xenograftsRadhika Iyer, Carly R Varela, Jane E Minturn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 27, 2024
Adult-Onset Cancer Predisposition Syndromes in Children and Adolescents-To Test or not to Test?Christian P Kratz, Philip J Lupo, Kristin Zelley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2005
Outcomes of children with intermediate-risk neuroblastoma after treatment stratified by MYCN status and tumor cell ploidyRochelle Bagatell, Pavlina Rumcheva, Wendy B London, et al.
Pageof 9